Use of Rosiglitazone-containing drugs restricted
11 views
Skip to first unread message
Nicholas Cheong
Oct 28, 2010, 8:39:27 PM10/28/10
to Medical Physiology at SOM, AIMST University
Dear members of forum,
Rosiglitazone (an anti-diabetic drug belonging to the
thiazolidinedione class of drugs) came under scrutiny by FDA (Food and
Drug Administration, US) and its European counterpart European
Medicines Agency (EMA). FDA is now limiting the use of rosiglitazone-
containing drugs in individuals with type 2 diabetes. In Malaysia, a
similar scenario is observed when the Drug Control Authority (DCA)
advises doctors not to prescribe the said drug to new patients.
Researches have shown that Rosiglitazone is linked with some
cardiovascular diseases. GlaxoSmithKline will convoke scientists to
study the drug further.
I have included a link below on a news item pertaining to this issue.
It is slightly outdated (published sept 26 in the Star) but I hope
that you all find it useful.
http://thestar.com.my/news/story.asp?file=/2010/9/26/nation/20100926164255&sec=nation
Best,
Nicholas Cheong
Rosiglitazone (an anti-diabetic drug belonging to the
thiazolidinedione class of drugs) came under scrutiny by FDA (Food and
Drug Administration, US) and its European counterpart European
Medicines Agency (EMA). FDA is now limiting the use of rosiglitazone-
containing drugs in individuals with type 2 diabetes. In Malaysia, a
similar scenario is observed when the Drug Control Authority (DCA)
advises doctors not to prescribe the said drug to new patients.
Researches have shown that Rosiglitazone is linked with some
cardiovascular diseases. GlaxoSmithKline will convoke scientists to
study the drug further.
I have included a link below on a news item pertaining to this issue.
It is slightly outdated (published sept 26 in the Star) but I hope
that you all find it useful.
http://thestar.com.my/news/story.asp?file=/2010/9/26/nation/20100926164255&sec=nation
Best,
Nicholas Cheong
Reply all
Reply to author
Forward
0 new messages